-
Your selected country is
Australia
- Change country/language
Old Browser
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
BD FastImmune™ Anti-Human 4-Color Dendritic Value Bundle
(RUO)
Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Description
This reagent combination can be used in the studies of: - Phenotyping of MDDC (monocyte-derived dendritic cell) preparations - Activation and maturation status of MDDC - Characterization and immune function of MDDC Contents: lineage cocktail 1 FITC (340546), CD123 (Anti—IL-3Ra) PE (340545), Anti—HLA-DR PerCP (347364), CD11c APC (340544), Mouse IgG1 PE (349043), and Mouse IgG2a APC (340473).
Description | Clone | Isotype | EntrezGene ID |
---|---|---|---|
APC Mouse IgG2a, κ Isotype Control | X39 | IgG2a, | 16071, 380793 |
APC Mouse Anti-Human CD11c | SHCL-3 | Human IgG2b, | 3687 |
PE Mouse Anti-Human CD123 | 9F5 | Human IgG1, κ | 3563 |
Anti-Human Lineage Cocktail 1 (lin 1) (CD3, CD14, CD16, CD19, CD20, CD56) | N/A | Human | 4684,916,931,930 |
PerCP Mouse Anti-Human HLA-DR | L243 | Human IgG2a, κ | 3122;3123;3125;3126;3127 |
PE Mouse IgG1, κ Isotype Control | X40 | IgG1, κ | 16017, 16071 |
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Refer to manufacturer's instructions for use and related User Manuals and Technical Data Sheets before using this product as described.
Comparisons, where applicable, are made against older BD technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.